Project Grant HT9425261E201
Award Date 7/1/26
Completion Date 6/30/29
Dollars Obligated $1.4M
Federal Agency
Federal Grant Program
Assistance Type
Project Grant
Place of Performance
Aurora, CO 80045, USA
Similar Awards
- Federal Grant Award Summary The University of Colorado-Denver received a $1.18 million Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for a three-year performance period from June 1, 2026, through May 31, 2029. The award supports research on the use of unconventional immune cells to treat rare melanomas and understand immunotherapy resistance. This research initiative aligns with the DHA's mission to advance biomedical...
- Federal Grant Award Summary The Defense Health Agency awarded the University of Colorado-Denver a $904,982 Project Grant effective June 1, 2026, through May 31, 2029, under the Military Medical Research and Development program (CFDA 12.420). The award supports research to investigate the use of unconventional immune cells in treating rare melanomas and understanding immunotherapy resistance. This research initiative aligns with the Defense Health Agency's mission to advance innovative biomedical...
- Federal Grant Award Summary The University of Colorado-Denver received a $624,000 Project Grant from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420) for the period of July 1, 2025, through June 30, 2027. The award supports research focused on targeting androgen receptors as a novel therapeutic strategy for advanced thyroid cancer. This research initiative aligns with the DHA's broader mission to transform healthcare for service members...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded University of Colorado-Denver a $907,432 Project Grant effective July 1, 2026 through June 30, 2029 under the Military Medical Research and Development program (CFDA 12.420). The award supports research focused on overcoming resistance to BRAF-directed therapy in advanced thyroid cancer. This research initiative represents a translational oncology effort aligned with the DHA's mission to advance innovative medical solutions...
- Federal Project Grant Award Summary The Defense Health Agency (DHA) awarded University of Colorado-Denver $842,067 under the Military Medical Research and Development program (CFDA 12.420) for the project "Overcoming Resistance to BRAF-Directed Therapy in Advanced Thyroid Cancer." The award, initiated July 1, 2026, with completion targeted for June 30, 2029, supports basic and applied biomedical research designed to advance innovative medical solutions for both military service members...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded a $2.87M Project Grant to The Regents of the University of Colorado (doing business as University of Colorado-Denver) on September 1, 2025, under the Military Medical Research and Development program (CFDA 12.420). The four-year award, which extends through August 31, 2029, supports research evaluating the Clinical, Biomarkers, Imaging, and Modifiers (CBI-M) classification system for traumatic brain injury (TBI). This research...
- Federal Grant Award Summary The University of Washington received a $1,494,943 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective April 1, 2026 through March 31, 2029. The award supports research and development services focused on biomaterial strategies to improve the specificity and efficacy of Chimeric Antigen Receptor (CAR) T cell therapy for breast cancer treatment. This research initiative aligns...
- Federal Grant Award Summary The University of Minnesota's Office of Sponsored Projects Administration received a $154,000 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective September 1, 2025 through August 31, 2027. The award supports research and development activities focused on dual-targeting Glucocorticoid/Dendritic (G/D) Chimeric Antigen Receptor (CAR)-T cell therapy for treating rhabdomyosarcoma, a...
- Federal Grant Award Summary The Defense Health Agency (DHA) awarded Beckman Research Institute of the City of Hope a $5.34 million Project Grant under the Military Medical Research and Development program (CFDA 12.420) on June 15, 2025, for a four-year performance period concluding June 14, 2029. The award supports development and implementation of a digital health intervention designed to enable self-management and telemonitoring capabilities for patients undergoing Chimeric Antigen Receptor...
- Federal Grant Award Summary The University of Southern California's Department of Contracts and Grants received a $1,092,695 Project Grant award from the Defense Health Agency (DHA) under the Military Medical Research and Development program (CFDA 12.420), effective August 1, 2025, through July 31, 2029. The award supports the Convergent Science Virtual Cancer Center, a research initiative focused on advancing biomedical solutions for cancer treatment and care delivery. Under this four-year...